Litigation

Recent Posts

High Court Will Consider Whether Reverse-Payment Settlements Are Anti-Competitive
Posted on 8 Dec 2012 by Joan Grossman

WASHINGTON, D.C. — (Mealey's) The Supreme Court on Dec. 7 granted the Federal Trade Commission’s petition for a writ of certiorari seeking consideration of whether reverse-payment settlements of patent litigation between the holder of... Read More

Tags: Supreme Court , Hatch-Waxman , Third Circuit , Second Circuit , Federal Circuit , Federal Trade Commission Act , scope-of-the-patent rule , Antitrust , Patent and Trademark Office , 11th Circuit , patent litigation , In re K-Dur Antitrust Litigation , Litigation , Patents , generic drugs , Federal Trade Commission , Federal Trade Commission v. Watson Pharmaceuticals , Watson Pharmaceuticals Inc. , FTC , patent infringement

Pharmaceutical Litigation Partner James Stronski Joins Crowell & Moring
Posted on 8 Jul 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - Crowell & Moring LLP has announced the addition of partner James K. Stronski to the firm's Intellectual Property Group. Based in the New York office, Stronski is an intellectual property litigator with extensive experience... Read More

Tags: New York lawyers , Hatch-Waxman , Crowell & Moring , Food Drug & Cosmetic Act , unfair competition , New York law firms , Frommer Lawrence & Haug , Patent , Intellectual Property , James K. Stronski , trade secret , Litigation , copyright , Chiemi D. Suzuki , trademark